Home
Home

Lonza

2 Under-Covered Pharma Stocks With Yields Above 3%

2 Under-Covered Pharma Stocks With Yields Above 3%
Seeking Alpha

Rituxan And Its Biosimilar Competitors

Rituxan And Its Biosimilar Competitors
Seeking Alpha

News

Stason Pharma gets world-wide non-exclusive license to use Lonza's GS Gene Expression System
Pharmabiz

News

Teva Gets Boost From Biosimilars
Seeking Alpha

News

Pharma Job Cuts Just Keep On Coming
Seeking Alpha
»

News

Human Genome Sciences signs supply deal for lupus drug Benlysta with Lonza
Yahoo/AP
»

News

Lonza: Patheon Bid Still Holds, Seeks JLL Talks
WSJ Online
»

News

Lonza Makes Offer Valuing Patheon at $460 Million
Bloomberg
»

News

Teva Ticks Up on Biogeneric Deal
TheStreet.com
»

News

Teva Pharmaceutical Industries, Lonza Group sign deal to make copies of biotech drugs
Yahoo/AP
»